Mesosil logo — Developing anti-infective biomaterials for medical devices.

Mesosil

Developing anti-infective biomaterials for medical devices.

Founded 2018 Canada Toronto, Canada 7 employees Seed Total: $2.88M Health Care, Manufacturing +1

General Information

Company Name Mesosil
Founded Year 2018
Location Canada Toronto, Canada +1
Employees 7
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Seed
Social

Get notified when Mesosil moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mesosil

Mesosil is a Canadian research startup founded in 2016, focusing on developing anti-infective biomaterials for medical devices. The company's slogan "Developing anti-infective biomaterials for medical devices" reflects its commitment to innovation in the Health Care industry. With a strong foundation in intellectual property developed at the University of Toronto, Mesosil is exploring the commercialization of its research in the Medical and Dental Devices space for infection treatment and disease prediction. The company recently secured a significant Seed Round investment on 01 January 2023 from the Archangel Network of Funds. This investment not only demonstrates confidence in the potential of Mesosil's technology but also provides the necessary capital to drive the company's growth and expansion. With its headquarters in Canada, Mesosil is strategically positioned to leverage the resources and expertise available in the country's thriving healthcare and innovation ecosystem. Mesosil's innovative approach to combating infections and predicting diseases using biomaterials sets it apart in the medical devices industry. With a promising trajectory and the backing of reputable investors, the company is well-positioned to make a meaningful impact in the healthcare sector. As Mesosil continues to progress, its developments have the potential to revolutionize the treatment and prevention of infections, ultimately improving patient outcomes and contributing to advancements in medical technology.

Taxonomy: biomaterials, anti-infective, research startup, commercialization, intellectual property, University of Toronto, infection treatment, disease prediction, IP development

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 5
Investor Investor Investor Investor
•••• ••••
05 Jun 2024
Seed Round •••••• 1
Investor
01 Jan 2023
Seed Round •••••• 4
Investor Investor Investor Investor
13 Jul 2021
Pre Seed Round •••••• - 01 Jan 2016

Mesosil Alternatives & Competitors

Mesosil vs

The AIC serves to fulfill the mission of protecting Albertans through the licensing and regulation o...

68 employees
Financial Services, Insurance
Mesosil vs

The oldest private scientific research institute on the Near and Middle East in Europe (founded by N...

4 employees
Social Media
Mesosil vs

Gwich'in land, culture, and economy for a better future.

Grant
34 employees
Government and Military, Social Media

FAQ About Mesosil

Developing anti-infective biomaterials for medical devices.
Mesosil was founded in 2018.
Mesosil is headquartered in Toronto, Canada.
Mesosil operates in the following industries: Health Care, Manufacturing, Medical Devices.
Mesosil has approximately 7 employees.
Mesosil has completed 4 funding rounds, raising a total of $2.88M. The latest funding stage is Seed.
Top alternatives and competitors to Mesosil include Alberta Insurance Council, German Orient-Institute, Gwich'in Tribal Council, Goshen Public Library and Historical Society, Greek Orthodox Archdiocese of America. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mesosil and Alberta Insurance Council are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mesosil and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes